Molxpert Diagnostics Private Limited
About Molxpert Diagnostics Private Limited
Data last updated:
Molxpert Diagnostics Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 27 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85300UP2018PTC109770.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shipra Gupta and Shailesh Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 16, Greater Noida, Uttar Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹74.48 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹11.83 Lakh (net margin 15.9%) and EBITDA of ₹16.84 Lakh (EBITDA margin 22.6%). Revenue has grown at a compounded annual rate (CAGR) of 76% over three years and 97% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 106 First Floor Mahagun Mart Plot No. Gh – 04 Sector 16C Greater Noid, A West, Greater Noida, Uttar Pradesh, India – 201301
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Molxpert Diagnostics Private Limited
The main business activity of Molxpert Diagnostics is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Molxpert Diagnostics Private Limited FY 2025 filings available
Molxpert Diagnostics Private Limited reported revenue of ₹74.48 Lakh (up 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Molxpert Diagnostics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 97% over five years, including 28% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Molxpert Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.84 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.83 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Molxpert Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 15.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Molxpert Diagnostics are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Molxpert Diagnostics Private Limited
Molxpert Diagnostics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Diagaid Pvt Ltd | ₹75.58 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Kolkata, West Bengal, India |
| G.M. Healthcare Private Limited | ₹74.87 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Bangalore, Karnataka, India |
| Lifecure Labs Private Limited | ₹74.87 Lakh (FY 2025) | •••• | •••• | 1003.0% | •••• | Panchkula, Haryana, India |
| Maval Healthcare Private Limited | ₹74.78 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Pune, Maharashtra, India |
| Personalized Medicine Institute Private Limited | ₹74.54 Lakh (FY 2019) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Molxpert Diagnostics Private Limited this company | ₹74.48 Lakh (FY 2024) | •••• | •••• | 28.0% | •••• | Greater Noida, Uttar Pradesh, India |
| SRT Healthcare Private Limited | ₹74.41 Lakh (FY 2024) | •••• | •••• | 173.0% | •••• | Shyamnagar, West Bengal, India |
| Ab Diagnopath Manufacturing Private Limited | ₹74.4 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Glycemia Anti Diabetic Clinic Private Limited | ₹74 Lakh (FY 2025) | •••• | •••• | 215.0% | •••• | Kannur, Kerala, India |
| Centromed Labs (Vijayawada) Private Limited | ₹73.77 Lakh (FY 2024) | •••• | •••• | •••• | Vijayawada, Andhra Pradesh, India | |
| Acclaim Health Care Private Limited | ₹73.69 Lakh (FY 2024) | •••• | •••• | 20.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Molxpert Diagnostics by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Molxpert Diagnostics Private Limited
Molxpert Diagnostics Private Limited is audited by M P R & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M P R & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Molxpert Diagnostics Private Limited
Molxpert Diagnostics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shipra Gupta | Director | 27 Oct 2018 | 7 Years 11 Months | Current |
| Shailesh Kumar Gupta | Director | 27 Oct 2018 | 7 Years 11 Months | Current |
Ownership and Shareholding of Molxpert Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Molxpert Diagnostics Private Limited
Molxpert Diagnostics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Molxpert Diagnostics Private Limited
Employment history and EPFO contributions of people linked to Molxpert Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Molxpert Diagnostics Private Limited
Molxpert Diagnostics Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Shailesh Kumar Gupta was appointed as Director on 27 Oct 2018.
Credit Ratings, Litigation & Regulatory Alerts for Molxpert Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Molxpert Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Molxpert Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Molxpert Diagnostics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Molxpert Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molxpert Diagnostics Private Limited
Molxpert Diagnostics is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 27 October 2018 (8+ years old) and is registered under CIN U85300UP2018PTC109770.
Molxpert Diagnostics reported revenue of ₹74.48 Lakh for FY 2024 (up 28% YoY).
Molxpert Diagnostics has 2 current directors:
- Shipra Gupta - Director
- Shailesh Kumar Gupta - Director
Molxpert Diagnostics reported a net profit of ₹11.83 Lakh (net margin 15.9%) and EBITDA of ₹16.84 Lakh (EBITDA margin 22.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Molxpert Diagnostics is 76% over three years and 97% over five years. In the latest year (FY 2024) revenue rose 28%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Molxpert Diagnostics is U85300UP2018PTC109770. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Molxpert Diagnostics was incorporated on 27 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Molxpert Diagnostics by revenue are Diagaid Pvt Ltd, G.M. Healthcare Private Limited, Lifecure Labs Private Limited, Maval Healthcare Private Limited, Personalized Medicine Institute Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Shailesh Kumar Gupta was appointed as Director on 27 Oct 2018. Shipra Gupta was appointed as Director on 27 Oct 2018.
The registered office of Molxpert Diagnostics is at Shop No 106 First Floor Mahagun Mart Plot No. Gh – 04 Sector 16C Greater Noid, A West, Greater Noida, Uttar Pradesh, India – 201301.
Molxpert Diagnostics has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.